The Executive Summary: World Market for Pain Management Drugs and Devices, 2nd Edition

Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market.

The report from which this Executive Summary is compiled is World Market for Pain Management Drugs and Devices, 2nd Edition , and the full study abstract is as follows:

Since more than 11 million Americans report pain as a significant disability, there’s no question that pain management is big business for healthcare practitioners today, and one area that market watchers need to understand. When viewed globally, there is a large underserved population for pain management medications, which indicates growth in what is now a 26 billion-dollar plus industry.

How big will the pain management drug and device market get in the next four years? Who are the key players that will lead this growth? What are the fastest-growing segments of pain management and which segments will just keep pace or fall? How will the Vioxx recall and Tylenol’s association with liver damage affect pain management market as a whole? What new drugs are in the pipeline and how are they expected to change the competitive landscape?

Kalorama’s World Market for Pain Management Drugs and Devices is your guide to the pain management marketplace. In great detail, the report analyzes the global marketplace for pain management products currently available and those in the product pipeline. Segmenting the market by pain indication, the report provides size, growth, and forecasts to 2010 for nine major pain indications:

• Burn Pain
• Cancer Pain
• Dental/Facial Pain
• Migraine Headache Pain
• MusculoSkeletal Pain
• Neuropathic Pain
• Obstetrical Pain
• Pediatric Pain
• Surgical and Trauma Pain